These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 15751073

  • 1. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 2. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 4. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.
    Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457
    [Abstract] [Full Text] [Related]

  • 5. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
    Ji JD, Cheon H, Jun JB, Choi SJ, Kim YR, Lee YH, Kim TH, Chae IJ, Song GG, Yoo DH, Kim SY, Sohn J.
    J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
    [Abstract] [Full Text] [Related]

  • 6. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Nov; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 8. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 9. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 10. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M.
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.
    Eur J Pharmacol; 2007 May 21; 562(3):247-58. PubMed ID: 17343846
    [Abstract] [Full Text] [Related]

  • 12. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.
    Arthritis Rheum; 2001 Feb 21; 44(2):451-62. PubMed ID: 11229477
    [Abstract] [Full Text] [Related]

  • 13. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
    Zhang H, Pi R, Li R, Wang P, Tang F, Zhou S, Gao J, Jiang J, Chen S, Liu P.
    Arch Biochem Biophys; 2007 Apr 01; 460(1):25-32. PubMed ID: 17346664
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
    Arthritis Res Ther; 2007 Apr 01; 9(2):R31. PubMed ID: 17386086
    [Abstract] [Full Text] [Related]

  • 15. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
    Maurin AC, Chavassieux PM, Meunier PJ.
    Calcif Tissue Int; 2005 May 01; 76(5):385-92. PubMed ID: 15868283
    [Abstract] [Full Text] [Related]

  • 16. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS, Lee RD, Kang SK, Han SY, Park KL, Yang KH, Song YS, Park HJ, Lee YM, Yun YP, Oh KW, Kim DJ, Yun YW, Hwang SJ, Lee SE, Hong JT.
    Exp Cell Res; 2004 Jul 15; 297(2):424-33. PubMed ID: 15212945
    [Abstract] [Full Text] [Related]

  • 17. Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts.
    Maret M, Chicheportiche R, Dayer JM, Gabay C.
    Cytokine; 2004 Mar 07; 25(5):193-203. PubMed ID: 15036245
    [Abstract] [Full Text] [Related]

  • 18. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 07; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D, Zeng BX, Zhang SH, Yao SL.
    Inflamm Res; 2005 Nov 07; 54(11):464-70. PubMed ID: 16307220
    [Abstract] [Full Text] [Related]

  • 20. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2004 Mar 07; 286(3):E329-36. PubMed ID: 14600076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.